TickerFactsScreenerDevelopers

Design Therapeutics, Inc. (DSGN) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2020: -$8.67M2021: -$29.38M2022: -$51.32M2023: -$58.56M2024: -$43.10M2025: -$54.36M-$54.36M
2020Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$54.36M-26.1%
2024-$43.10M+26.4%
2023-$58.56M-14.1%
2022-$51.32M-74.7%
2021-$29.38M-238.9%
2020-$8.67M—